A characteristic of memory T (T M ) cells is their ability to mount faster and stronger responses to reinfection than naïve T (T N ) cells do in response to an initial infection. However, the mechanisms that allow this rapid recall are not completely understood. We found that CD8 T M cells have more mitochondrial mass than CD8 T N cells and, that upon activation, the resulting secondary effector T (T E ) cells proliferate more quickly, produce more cytokines, and maintain greater ATP levels than primary effector T cells. We also found that after activation, T M cells increase oxidative phosphorylation and aerobic glycolysis and sustain this increase to a greater extent than T N cells, suggesting that greater mitochondrial mass in T M cells not only promotes oxidative capacity, but also glycolytic capacity. We show that mitochondrial ATP is essential for the rapid induction of glycolysis in response to activation and the initiation of proliferation of both T N and T M cells. We also found that fatty acid oxidation is needed for T M cells to rapidly respond upon restimulation. Finally, we show that dissociation of the glycolysis enzyme hexokinase from mitochondria impairs proliferation and blocks the rapid induction of glycolysis upon T-cell receptor stimulation in T M cells. Our results demonstrate that greater mitochondrial mass endows T M cells with a bioenergetic advantage that underlies their ability to rapidly recall in response to reinfection. In addition, several intrinsic aspects of T M cells have been suggested to contribute to their ability to respond more efficiently, such as increased activity of proximal TCR signaling components, an "open" chromatin conformation of cytokine genes, and altered transcriptional profiles (1, 2, 5-9). However, whether bioenergetic differences contribute to this process is not clear.
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metabolism | lymphocytes N aïve T (T N ) and memory T (T M ) cells are quiescent, but upon T-cell receptor (TCR)-mediated recognition of antigen (Ag) and costimulation, they become activated, undergo clonal expansion, and acquire effector functions. Although both T N and T M cells acquire effector functions, a noted characteristic of T M cells is their ability to respond more rapidly than T N cells to Ag (1) (2) (3) (4) . Several factors underlie the accelerated recall response of T M cells. For example, Ag-specific T M cells are present in greater numbers than T N cells. In addition, several intrinsic aspects of T M cells have been suggested to contribute to their ability to respond more efficiently, such as increased activity of proximal TCR signaling components, an "open" chromatin conformation of cytokine genes, and altered transcriptional profiles (1, 2, 5-9). However, whether bioenergetic differences contribute to this process is not clear.
Resting cells like T N and T M cells interchangeably use glucose, amino acids, and lipids to fuel the tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS) for ATP production (10) (11) (12) . However, proliferating cells like activated T cells promote aerobic glycolysis, which supports cell growth, proliferation, and effector functions (13) (14) (15) (16) . Although T N and T M cells both have a similar metabolism, there are metabolic differences between these cells (17) . T M cells from Listeria monocytogenes-infected mice have more mitochondria than T N cells, which is consistent with our finding that T M cells but not T N cells have considerable spare respiratory capacity (SRC) (17) . Because SRC is important for cellular survival and function (17) (18) (19) and T M cells are characterized by their ability to respond vigorously to Ag reencounter (20) , we investigated whether bioenergetic differences between T M and T N cells contribute to the ability of T M cells to rapidly recall in response to reinfection. We show here that T M cells have more mitochondria and ATP than T N cells and that, upon activation, secondary T E cells proliferate faster, produce cytokines more quickly, and maintain more ATP than primary effector T (T E ) cells. In addition, T M cells use both OXPHOS and glycolysis to a greater and more prolonged degree after activation than T N cells, suggesting that more mitochondria in T M cells not only promote OXPHOS, but also glycolysis. We show that both the rapid proliferation and induction of glycolysis in T M cells depend on mitochondrial ATP. We also found that optimal mitochondrial function is predominantly fueled by fatty acid oxidation (FAO) in T M cells and depends on the association of hexokinase (HK) with mitochondria. Thus, our data demonstrate that greater mitochondrial mass underlies the rapid recall ability of T M cells.
Results
To explore whether bioenergetic differences between T M and T N cells account for the ability of T M cells to rapidly recall upon activation, we generated "memory" T cells in vitro by activating OT-I T N cells with OVA peptide and IL-2 for 3 d and then differentially cultured cells for 3-4 additional days in IL-15 (17, 21) . To determine whether IL-15 T M cells have more mitochondria than T N cells, as we have shown for T M cells generated after infection (17) , we stained cells with Mitotracker green and found that IL-15 T M cells had more mitochondrial mass ( Fig. 1 A  and B) . Although IL-15 T M cells are slightly bigger than T N cells, greater size does not necessarily correlate with increased mitochondrial content. We have shown that in vitro-generated IL-2-induced T E (IL-2 T E ) cells are much larger than IL-15 T M cells and actually have less mitochondrial content (17) . IL-15 T M cells also have a significantly higher ratio of mitochondrial DNA/nuclear DNA (mtDNA/nDNA) than T N cells (Fig. 1C) . Together these data indicate that in vitro-generated IL-15 T M cells, like T M cells generated after infection (17) , have greater mitochondrial mass than T N cells and provide a model from which to study bioenergetic differences between these cells.
To verify that IL-15 T M cells respond faster to stimulation than T N cells, we measured proliferation of T N and IL-15 T M cells after activation with anti-CD3/28. Secondary T E cells (derived from IL-15 T M cells) proliferated faster than primary T E cells (derived from T N cells; Fig. 2A ). We also found that secondary T E cells produced more IFN-γ (Fig. 2B ) and IL-2 (Fig. S1 ). Together, these data confirm that IL-15 T M cells proliferate more quickly and produce more cytokines after activation than T N cells.
To determine whether differences in mitochondrial content between T N and IL-15 T M cells result in metabolic differences after activation, we stained cells with Mitotracker Deep Red, a dye that localizes to respiring mitochondria. Secondary T E cells proliferated faster and had more respiring mitochondria than primary T E cells (Fig. 3A) . We also measured O 2 consumption rates (OCR), an indicator of OXPHOS, and extracellular acidification rates (ECAR), an indicator of aerobic glycolysis. Two days after restimulation, secondary T E had higher OCR and ECAR than primary T E cells (Fig. 3B) , indicating increased OXPHOS and aerobic glycolysis, respectively, and correlating with the faster proliferation of these cells ( Figs. 2A and 3A) . We measured ATP and found that secondary T E cells have more ATP than primary T E cells after restimulation and that resting IL-15 T M cells have more ATP than resting T N cells (Fig. 3 C  and D) . Taken together, these data demonstrate that secondary T E cells have more metabolic activity and ATP than primary T E cells.
Given our findings that IL-15 T M cells have enhanced mitochondrial content and more ATP than T N cells, we next determined their metabolic phenotype in resting conditions. IL-15 T M cells had higher OCR and ECAR than T N cells (Fig. 4A ), indicating that resting IL-15 T M cells are metabolically more active. Relative utilization of glycolysis and OXPHOS, as indicated by OCR/ECAR ratio, is the same in both cells (Fig. 4A) , suggesting that the IL-15 T M cells revert to a quiescent metabolic state rather than preferentially using glycolysis over OXPHOS like activated T E cells. Because T M cells respond to reinfection more rapidly than T N cells, we measured the bioenergetics of T cells immediately after activation. We activated T N and IL-15 T M cells with anti-CD3/28 and found that IL-15 T M cells increased OCR and ECAR (Fig. 4B ). As T N cells minimally responded in this time frame, we used a stronger stimulus that would also bypass differences in TCR signaling (6) . T N and IL-15 T M cells rapidly increased OCR after PMA/ionomycin (iono) (Fig. 4 C and D), which was proportionally similar at the peak, but more sustained in IL-15 T M cells. Both T N and IL-15 T M cells increased ECAR after PMA/iono; however, this increase was higher at the peak and sustained longer in IL-15 T M cells, indicating their greater capacity to promote and sustain glycolysis upon stimulation (Fig. 4 C and D) . Furthermore, unlike T N cells, mitochondrial activity in IL-15 T M cells remained intact after PMA/iono, as indicated by increased OCR in response to the uncoupler carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), which reveals maximum respiratory capacity, in the presence of oligomycin (oligo) (blocks ATP synthase), and decreased OCR after etomoxir (FAO inhibitor), and rotenone plus antimycin A (R+A) [electron transport chain (ETC) inhibitors] (Fig. S2 ). Together these data indicate that IL-15 T M cells are bioenergetically different from T N cells and have a greater capacity to promote and sustain glycolysis and OXPHOS after activation.
We next questioned how having more mitochondrial mass could contribute to the rapid recall ability and the enhanced glycolytic capacity of IL-15 T M cells. We activated T N and IL-15 T M cells with anti-CD3/28 and followed proliferation in the absence or presence of oligo. Similar to our findings in CD4 T N cells (16) , initiation of proliferation of both CD8 T N and IL-15 T M cells was impaired in the presence of low doses of oligo (5-10 nM) ( Fig. 5A and Fig. S3 ). In contrast, even high doses of oligo (1 μM) did not stop proliferation of actively proliferating T cells (Fig. 5B) , showing that the initiation of proliferation, rather than the process of active proliferation, requires mitochondrial ATP. The low doses of oligo that inhibited proliferation ( Fig. 5A ) also reduced OCR (Fig. 5C ). Together these data indicate that although IL-15 T M cells were previously activated, they have returned to a resting metabolic state and have the same requirements for activation as T N cells. To determine whether mitochondrial ATP was required for the greater glycolytic capacity of IL-15 T M cells, we added oligo together with PMA/iono. The increase in OCR after activation was diminished in IL-15 T M cells when low doses of oligo were present (Fig. 5D ), indicating that OXPHOS is induced after activation and produces mitochondrial ATP. The increase in ECAR in IL-15 T M cells after activation was also inhibited by low doses of oligo (Fig. 5D ), suggesting that mitochondrial ATP is needed for the induction of glycolysis and the rapid proliferation of IL-15 T M cells after activation.
We next measured the bioenergetics of in vivo-generated T M cells isolated from L. monocytogenes (expressing OVA, LmOva) infected mice. Anti-CD3/28 stimulation increased OCR and ECAR in T M cells and, to a lesser extent, ECAR in polyclonal T N cells (Fig. 6A) . Two hours after activation, both cell types responded to oligo, FCCP, and R+A (Fig. 6B) , indicating intact mitochondrial function. In addition, both T N and T M cells rapidly increased ECAR and OCR after PMA/iono, which was sustained in T M but not T N cells (Fig. 6 C and D) . Like IL-15 T M cells (Fig. S2) , T M cells increased OCR when exposed to oligo plus FCCP 2 h after activation and reduced OCR after R+A, whereas T N cells did not (Fig. 6C ). Together these data indicate that T M cells sustain glycolysis and OXPHOS after activation and that their mitochondrial function remains intact after PMA/ iono. T N cells did not lose mitochondrial function when exposed to media (Fig. S4) or anti-CD3/28 (Fig. 6B) , suggesting that this loss of mitochondrial function is not an intrinsic defect of T N cells, but rather a result of PMA/iono. We also verified that resting T M cells had more ATP than T N cells, which was not due to greater cell size (Fig. 6E) . Likewise, secondary T E cells derived from T M cells had more ATP (Fig. 6F ) and proliferated faster than primary T E cells, whereas the initiation of proliferation in both T N and T M cells was impaired by low doses of oligo (Fig. 6G) (17) . To determine whether FAO contributes to the mitochondrial ATP required for T M cell activation, we activated T M and IL-15 T M cells in the presence of etomoxir and followed proliferation. We found that proliferation was attenuated, but not completely suppressed, when FAO was blocked (Fig. 7 A and  B and Fig. S5 ), suggesting that FAO contributes to, but is not the only pathway fueling OXPHOS in these cells. T N cell proliferation was also reduced when FAO was blocked (Fig. S6) . To test whether FAO inhibition impairs the rapid induction of glycolysis after activation, we exposed IL-15 T M cells to etomoxir immediately before activation with PMA/iono. Etomoxir inhibited the increase in OCR and blunted ECAR after activation (Fig. 7C) , indicating that FAO fuels OXPHOS and contributes to the rapid activation of IL-15 T M cells. T M cells in the presence of etomoxir failed to increase OCR, but not ECAR, after PMA/ iono (Fig. S7) , and also failed to increase OCR after oligo plus FCCP, indicating that FAO contributes to the maximum respiratory capacity after activation. We also modulated the expression of carnitine palmitoyltransferase 1a (CPT1a), a protein that is the rate-limiting step to FAO, and the target of etomoxir (22, 23) . We transduced T cells with retrovirus expressing shRNA against CPT1a (hpCPT1a) (17) . Inhibiting CPT1a expression in IL-15 T M cells slowed initial proliferation after anti-CD3/28 activation (Fig. 7D) , although this effect was more subtle and variable than the consistently strong inhibition by etomoxir. To investigate whether pyruvate fuels this process, we used a retrovirus expressing shRNA against the mitochondrial pyruvate carrier (hpMPC1) (24) . Although this shRNA resulted in lower MPC1 mRNA expression (Fig. S8) , there was no difference in proliferation compared with the control cells (Fig. 7D) . Consistent with our data showing that FAO contributes to the proliferation of IL-15 T M cells after activation, we found that hpCPT1a IL-15 T M cells had impaired induction of OCR and ECAR after PMA/iono stimulation, whereas hpMPC1 IL-15 T M cells did not (Fig. 7 E and F) . Flux analysis of 13 C-glucose comparing IL-2 T E cells, which are highly glycolytic and use substantial amounts of glucose, to IL-15 T M cells showed that the relative abundance of unlabeled carbon was greater than that of labeled carbon for TCA cycle intermediates in IL-15 T M cells (Fig. S9) . These data indicate that pyruvate flux into the TCA cycle is lower in IL-15 T M cells, which may suggest that other substrates contribute to OXPHOS. Together these data indicate that FAO fuels the OXPHOS required for the rapid recall response of IL-15 T M cells.
We next wanted to determine how mitochondrial ATP could contribute to the rapid increase in glycolysis in IL-15 T M cells upon activation. HK mediates the ATP-dependent conversion of glucose into glucose-6-phosphate in the first step of glycolysis. Upon T-cell activation, HK is recruited to the mitochondria where ATP is abundant (25) . We used clotrimazole (CLT), a drug that dissociates HK from the mitochondria (Fig. 8A) (26) , or peptides that consist of the N-terminal sequence of HK and compete with HK for mitochondrial binding (27, 28) , to explore whether mitochondrial-associated HK is critical for the rapid induction of glycolysis in (IL-15) T M cells. We found that the ability of IL-15 T M cells to rapidly increase OCR and ECAR after PMA/iono was impaired in the presence of CLT or HK peptides ( Fig. 8B and Fig. S10 ). CLT did not destroy mitochondrial activity, because R+A decreased OCR after CLT (Fig.  S11A) . Likewise, 10 μM of either HK-1 or HK-2 peptides left OXPHOS intact, whereas the combination of both resulted in the inability to increase OCR after oligo + FCCP (Fig. S11B) , indicating a loss of mitochondrial function. In addition, IL-15 T M and T N cell proliferation after anti-CD3/28 stimulation was impaired by CLT (Fig. 8C and Fig. S12 ) or HK-1 competing peptide (Fig. 8D) . CLT also decreased proliferation (Fig. 8E) and impaired OCR and ECAR after activation (Fig. 8F) in T M cells. Mitochondrial function remained intact in T M cells treated with CLT as shown by the increase in OCR after oligo plus FCCP and decrease in OCR after R+A (Fig. 8F) . These data indicate that mitochondria-associated HK is critical for the rapid induction of glycolysis and proliferation of (IL-15) T M cells. 
Discussion
We propose a model where substantial mitochondrial mass and ATP enable T M cells to rapidly recall upon restimulation. The enhanced availability of mitochondrial ATP provides the energy that is required for the rapid engagement of glycolysis observed in T cells after activation. The HK-mediated conversion of glucose into glucose-6-phosphate requires ATP, and we show here that blocking the generation of mitochondrial ATP, and the dissociation of HK from the mitochondria, impair the rapid induction of glycolysis and hamper the fast proliferation of T M cells after activation. The proliferation of T N cells after activation was also impaired when mitochondrial ATP was unavailable, suggesting that both T N and T M cells have similar requirements for activation and that quantitative bioenergetic differences underlie the distinct abilities of these cells to respond to Ag. Qualitative bioenergetic differences may also exist between T N and T M cells. Although both T N and T M cells increased glycolysis after anti-CD3/28, and responded to uncoupling and ETC inhibitors, T N cells lost metabolic activity after PMA/iono, suggesting that after this stimulation, T N cells cannot efficiently fuel their mitochondria, whereas T M cells can. Several factors could contribute to this disparity, such as differences in the strength of activation, the signaling pathways involved, or the acquisition or storage of substrates.
Although quantitative differences in Ag-specific T N and T M cells can contribute to the superior protection conferred by T M cells upon reinfection, studies where equal cell numbers were transferred into mice have shown that these cells respond with distinct kinetics (1, 3, 5, 29, 30) . T M cells enter the cell cycle earlier and proliferate faster than T N cells after activation (3) (4) (5) . Because T M cells are different from T N cells in their ability to migrate to peripheral tissues (30) (31) (32) , these experiments do not exclude the possibility that T M cells respond more quickly because they encounter Ag before T N cells. Consistent with previous studies (3, 4, 33) , we show here that T M cells are intrinsically different as they proliferate faster and make more cytokine after activation in vitro. This more ready-to-respond state of T M cells has been attributed to several intrinsic differences such as an "open" chromatin conformation of cytokine genes, altered transcription profiles, and enhanced activity of proximal TCR signaling components (1, 2) . We now show here that rapid proliferation and engagement of glycolysis by T M cells after activation requires mitochondrial ATP to enable optimal HK function. Although primary T E cells have been shown to exhibit prolonged proliferation after infection compared with secondary T E cells (5, 34) , and ultimately T N cells have a greater per-cell expansion than T M cells (34), these observations do not contradict that T M cells have a greater capacity to proliferate more rapidly immediately after stimulation. CD8 T M cells use FAO, which contributes to their substantial SRC that is important for survival and stable T M development (17) . We show here that FAO in T M cells also provides the substrates, at least partly, for the OXPHOS that is required for the rapid induction of glycolysis and the fast proliferative response of these cells. When IL-15 T M cells are transduced with the hpCPT1a retrovirus, the effect on the inhibition of OCR and proliferation is more subtle and variable than when fully differentiated IL-15 T M cells are acutely exposed to etomoxir. Our published data show 50% reduction in CPT1a mRNA by using this construct (17) , suggesting only partial FAO inhibition. Unlike direct exposure to etomoxir, the hpCPT1a retrovirus does not acutely impair FAO. When transduced cells are cultured for 5 d before proliferation and OCR are measured, it is likely that they adapt and begin to rely less on FAO. Given the importance of CPT1a in in vivo T M cell development, and that IL-15 induces CPT1a expression in vitro (17), we expect that the hpCPT1a-transduced T cells that do survive until day 6 in the IL-15 cultures are selected on their ability to use other substrates, i.e., Compiled and baselined data as shown in E, from three experiments; peak is at first measurement after PMA/iono, plateau is at 120 min. n.s., not significant. *P < 0.05; mean ± SEM (E and F) and representative of two (D) or four (E) experiments. Fig. 6G and 7A, from one experiment (E); OCR and ECAR after PMA/iono ± CLT and exposed to oligo (1 μM) plus FCCP (1.5 μM), and rotenone (100 nM) plus antimycin A (1 μM); mean ± SEM and representative of two experiments; control is the same as Fig. 6C and Fig. S7 (F ) .
cells that rely most heavily on FAO while expressing hpCPT1a might not survive. This phenomenon could explain the more striking effect on proliferation and OCR when FAO is acutely inhibited by etomoxir. Our data also suggest that pyruvate flux via MPC does not substantially contribute to OXPHOS in T cells during the recall response. Although we have not ruled out the possibility that pyruvate still enters the mitochondria in hpMPC cells, it is likely that, in addition to long chain fatty acids, glutamine or medium and short chain fatty acids contribute to OXPHOS in T M cells.
Our results indicate that mitochondrial association of HK is important for the rapid recall of T M cells. Recruitment of HK to the mitochondria happens quickly in response to Akt activation (25) , and the conversion of glucose into glucose-6-phosphate is a process that requires ATP. Because mitochondrial HK has been shown to exclusively use intramitochondrial ATP to phosphorylate glucose (35-37), we speculate that the direct availability of ATP supports the rapid activation of HK when associated with mitochondria. Higher expression of glycolysis enzymes in T M cells might also account for their capacity to quickly increase glycolysis.
OT-I T N cells did not increase OCR or ECAR after anti-CD3/ 28, whereas polyclonal T N cells slightly increased ECAR. It is possible that this difference would not occur if given more time or a stronger stimulus, or perhaps polyclonal T N cells exist in a slightly more activated state than transgenic T N cells and that this more activated state contributes to their faster metabolic activity. We also found that etomoxir inhibited the increase in OCR, but not ECAR, in T M cells after PMA/iono, differing from IL-15 T M cells, which show a decrease in both ECAR and OCR. These data suggest that T M cells are able to engage glycolysis briefly after PMA/iono in the presence of etomoxir, but importantly, this engagement is dissipated after oligo and FCCP. This difference may be due to the fact that IL-15 T M cells are a homogenous population exposed to optimized culture conditions, whereas in vivo-generated T M cells have varied substrate and growth factor availability and might not rely solely on FAO to initially engage glycolysis after activation, but need it to maintain mitochondrial and glycolytic activity when maximal respiratory capacity is required.
We show here that bioenergetic differences between CD8 T N and T M cells contribute to the differential responses of CD8 T N and T M cells to activation, i.e., greater mitochondrial mass endows T M cells with the ability to rapidly recall. Agents that induce mitochondrial biogenesis have been of interest for treatment of numerous pathologies (38) . Our findings indicate that drugs that induce mitochondrial biogenesis could hold promise as immunotherapeutics to improve vaccination strategies.
Materials and Methods
Full methods are available as SI Materials and Methods. Mice were purchased from Jackson Laboratory. OT-I cells were activated with OVA-peptide and IL-2 for 3 d and, subsequently, cultured in the presence of IL-2 or IL-15 for 3-4 d to generate IL-2 T E and IL-15 T M cells, respectively (17) . OCR and ECAR were measured by using the XF-24 or XF-96 Extracellular Flux Analyzers (Seahorse Bioscience). Statistical comparisons for two groups were calculated by using unpaired two-tailed Student's t tests.
